Iprocess Clinical Marketing Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 7 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 63.18%
- Profit Growth -54.87%
- Ebitda 41.86%
- Net Worth 10.32%
- Total Assets 22.71%
About Iprocess Clinical Marketing
Iprocess Clinical Marketing Private Limited (ICMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 February 2006 and has a history of 19 years. Its registered office is in Bangalore, Karnataka.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohammed Saleem and Manoj Singh serve as directors at the Company.
Company Details
-
LocationBangalore, Karnataka
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51507KA2006PTC038365
-
Company No.
038365
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Feb 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Iprocess Clinical Marketing?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohammed Saleem
|
Director | 01-Feb-2006 | Current |
|
Manoj Singh
|
Director | 20-Jul-2022 | Current |
Financial Performance of Iprocess Clinical Marketing.
Iprocess Clinical Marketing Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 63.18% increase. The company also saw a substantial fall in profitability, with a 54.87% decrease in profit. The company's net worth Soared by an impressive increase of 10.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Iprocess Clinical Marketing?
In 2017, Iprocess Clinical Marketing had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Iprocess Clinical Marketing?
Iprocess Clinical Marketing has a workforce of 15 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Iprocess Clinical Marketing, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iprocess Clinical Marketing's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
